Portfolio comparison
Washington University in St. Louis vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Washington University in St. Louis
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticalgene_editingoncology
Top Patents1 enriched
US 12564648· 2026
Gene Editing T-Cells to Fight CD7 Blood Cancers
Activity by Decade
2020s1
Company B
Immatics Biotechnologies
Patents indexed
9
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents9 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 12006349· 2024
How a Specific Peptide Can Train Your Immune System to Fight Cancer
Activity by Decade
2010s3
2020s6
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.